Profilo
Sarah C.
DiSalvatore worked as Vice President-Clinical Operations at Beacon Therapeutics (USA), Inc. from 2021 to 2023.
Prior to that, she worked as Associate Vice President-Clinical Operations at Rocket Pharmaceuticals, Inc.
Precedenti posizioni note di Sarah DiSalvatore
| Società | Posizione | Fine |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/04/2023 |
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
- Borsa valori
- Insiders
- Sarah DiSalvatore
